Skip to main content

Table 1 Comparisons of ages and pathological types of patients between two groups

From: Comparisons of the survival time of patients with ovarian cancer adopting post-operative chemotherapy by use of paclitaxel combined with carboplatin or nedaplatin

 

CBP (n = 48)

NDP (n = 46)

Statistics

P value

Age

50.75 ± 8.566

51.87 ± 9.854

t = 0.589

0.558

Pathological type

  

\( \chi \) 2 = 0.091

0.763

Poorly differentiated adenocarcinoma (30)

16

14

  

Papillary serous adenocarcinoma (64)

32

32